Levaquin: Potent Fluoroquinolone Antibiotic for Severe Infections
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.71 | $51.21 (0%) | 🛒 Add to cart |
| 60 | $1.51 | $102.41 $90.36 (12%) | 🛒 Add to cart |
| 90 | $1.31 | $153.62 $117.47 (24%) | 🛒 Add to cart |
| 120 | $1.15 | $204.82 $138.56 (32%) | 🛒 Add to cart |
| 180 | $1.00 | $307.23 $180.73 (41%) | 🛒 Add to cart |
| 270 | $0.90 | $460.85 $243.98 (47%) | 🛒 Add to cart |
| 360 | $0.87
Best per pill | $614.47 $314.26 (49%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.01 | $40.16 (0%) | 🛒 Add to cart |
| 30 | $1.91 | $60.24 $57.23 (5%) | 🛒 Add to cart |
| 60 | $1.81 | $120.48 $108.44 (10%) | 🛒 Add to cart |
| 90 | $1.65 | $180.73 $148.60 (18%) | 🛒 Add to cart |
| 120 | $1.51 | $240.97 $180.73 (25%) | 🛒 Add to cart |
| 180 | $1.26 | $361.45 $225.91 (38%) | 🛒 Add to cart |
| 270 | $1.13 | $542.18 $306.23 (44%) | 🛒 Add to cart |
| 360 | $1.03
Best per pill | $722.90 $371.49 (49%) | 🛒 Add to cart |
| Product dosage: 750mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.21 | $44.18 (0%) | 🛒 Add to cart |
| 30 | $2.01 | $66.27 $60.24 (9%) | 🛒 Add to cart |
| 60 | $1.91 | $132.53 $114.46 (14%) | 🛒 Add to cart |
| 90 | $1.71 | $198.80 $153.62 (23%) | 🛒 Add to cart |
| 120 | $1.61 | $265.07 $192.77 (27%) | 🛒 Add to cart |
| 180 | $1.41 | $397.60 $253.02 (36%) | 🛒 Add to cart |
| 270 | $1.32 | $596.40 $357.44 (40%) | 🛒 Add to cart |
| 360 | $1.20
Best per pill | $795.20 $433.74 (45%) | 🛒 Add to cart |
Synonyms
| |||
Levaquin (levofloxacin) is a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of adults with serious bacterial infections. As a third-generation fluoroquinolone, it demonstrates enhanced activity against Gram-positive pathogens while maintaining excellent coverage against Gram-negative organisms. Its superior bioavailability and tissue penetration make it a valuable therapeutic option for combating complex infections where other antibiotics may fail. Healthcare providers rely on Levaquin for its proven efficacy in treating respiratory, urinary, skin, and other systemic infections caused by susceptible strains of bacteria.
Features
- Contains levofloxacin, the L-isomer of ofloxacin with doubled antibacterial activity
- Available in oral tablets (250mg, 500mg, 750mg), oral solution, and intravenous formulations
- Broad-spectrum coverage including both Gram-positive and Gram-negative bacteria
- Excellent tissue penetration with concentrations exceeding plasma levels in lungs, skin, and prostate
- Once-daily dosing regimen for improved patient compliance
- Rapid bactericidal action through inhibition of DNA gyrase and topoisomerase IV
Benefits
- Effective against multidrug-resistant pathogens including some Pseudomonas aeruginosa strains
- High clinical cure rates in complicated urinary tract infections and pyelonephritis
- Superior lung tissue concentration ideal for treating community-acquired pneumonia
- Reduced treatment duration compared to many alternative antibiotic regimens
- Convenient IV-to-oral switch therapy allowing for early hospital discharge
- Proven efficacy in managing complicated skin and skin structure infections
Common use
Levaquin is commonly prescribed for the treatment of adults with: acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infections, acute pyelonephritis, uncomplicated urinary tract infections, chronic bacterial prostatitis, complicated skin and skin structure infections, and inhalational anthrax exposure. It is also used as part of multi-drug regimens for certain mycobacterial infections. The antibiotic demonstrates particular value in cases where penicillin-allergic patients require broad-spectrum coverage or when resistant organisms are suspected.
Dosage and direction
Dosage varies based on infection type and severity. For most indications: 500mg once daily for 7-14 days. For complicated urinary tract infections or acute pyelonephritis: 250mg once daily for 10 days. For community-acquired pneumonia: 750mg once daily for 5 days. For chronic bacterial prostatitis: 500mg once daily for 28 days. Administer tablets with a full glass of water, with or without food. Maintain adequate hydration during treatment. Complete the full course of therapy even if symptoms improve earlier. Dosage adjustment required in renal impairment (CrCl <50 mL/min). Intravenous administration should be infused over 60 minutes for 250mg or 500mg doses, and over 90 minutes for 750mg doses.
Precautions
Monitor patients for tendon pain, swelling, or inflammation; discontinue immediately if tendinitis suspected. Use with caution in patients with CNS disorders (e.g., epilepsy) due to potential seizure risk. May prolong QT interval; avoid in patients with known QT prolongation, uncorrected hypokalemia, or concurrent use of other QT-prolonging drugs. Photosensitivity reactions may occur; advise patients to avoid excessive sunlight and UV exposure. Periodic assessment of renal, hepatic, and hematopoietic function recommended during prolonged therapy. Use caution in elderly patients due to increased risk of tendon disorders. Diabetic patients should monitor blood glucose carefully due to potential hypoglycemic effects.
Contraindications
Known hypersensitivity to levofloxacin, other quinolone antibiotics, or any product components. History of tendon disorders related to fluoroquinolone use. Concurrent administration with tizanidine due to potentially fatal interaction. Patients with myasthenia gravis due to risk of life-threatening respiratory compromise. Pediatric patients (except for inhalational anthrax post-exposure) and pregnant women unless no alternative exists. Patients with known QT prolongation or ventricular arrhythmia. Avoid in patients with history of peripheral neuropathy.
Possible side effect
Common: nausea (3-7%), diarrhea (1-5%), headache (3-6%), constipation (1-3%), dizziness (1-3%). Less common: tendonitis, tendon rupture, peripheral neuropathy, CNS effects (insomnia, anxiety, confusion), photosensitivity, elevated liver enzymes. Rare but serious: QT prolongation, torsades de pointes, hypoglycemia, hepatic toxicity, severe skin reactions (Stevens-Johnson syndrome), Clostridium difficile-associated diarrhea, blood dyscrasias. Musculoskeletal side effects may occur months after treatment completion. Discontinue immediately at first sign of tendon pain, peripheral neuropathy, or serious allergic reaction.
Drug interaction
Significant interactions with: antacids containing magnesium/aluminum, sucralfate, iron preparations, multivitamins with zinc (reduce absorption; separate administration by至少2 hours). Warfarin (increased anticoagulant effect; monitor INR closely). NSAIDs (increased CNS stimulation and seizure risk). Corticosteroids (increased risk of tendon rupture). Oral hypoglycemic agents or insulin (enhanced hypoglycemic effect). QT-prolonging drugs (additive effect on cardiac repolarization). Theophylline (increased theophylline levels). Cyclosporine (elevated serum creatinine). Probenecid (reduced renal clearance of levofloxacin).
Missed dose
Take the missed dose as soon as remembered, unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed dose. Maintain the regular dosing schedule. If multiple doses are missed, contact healthcare provider for guidance. Consistent antibiotic levels are crucial for effective bacterial eradication and prevention of resistance development.
Overdose
Symptoms may include: CNS excitation (seizures, dizziness, tremor), gastrointestinal distress, prolonged QT interval. Management is supportive with ECG monitoring for至少24-48 hours. Hemodialysis removes approximately 10-20% of dose. Maintain adequate hydration. No specific antidote exists. Symptomatic treatment for seizures (benzodiazepines) and arrhythmias (standard antiarrhythmic measures). Contact poison control center for latest guidance. Patients should be monitored for secondary complications including electrolyte disturbances and renal impairment.
Storage
Store at controlled room temperature (20-25°C or 68-77°F). Protect from light and excessive moisture. Keep container tightly closed. Do not store in bathroom medicine cabinet due to humidity fluctuations. Keep out of reach of children and pets. Oral solution should not be frozen. Discard any unused medication after completion of therapy. Do not flush medications down toilet or pour into drain unless instructed to do so.
Disclaimer
This information does not replace professional medical advice. Consult healthcare provider for diagnosis and appropriate treatment decisions. Use only as prescribed. Serious side effects may occur; report any adverse reactions to healthcare provider immediately. Antibiotics should be used only for bacterial infections as improper use contributes to antibiotic resistance. Not all patients are candidates for fluoroquinolone therapy due to risk-benefit considerations.
Reviews
Clinical studies demonstrate Levaquin’s efficacy with clinical success rates of 85-95% across various indications. The antibiotic shows particular strength in treating respiratory infections with 93% clinical cure rates in pneumonia trials. Urological studies report 89% bacteriological eradication in complicated UTIs. Dermatological research indicates 86% success in skin structure infections. However, post-marketing surveillance confirms the serious adverse effect profile, with tendon disorders reported in approximately 0.1-0.4% of patients. Many infectious disease specialists reserve Levaquin for cases where benefits clearly outweigh risks and alternative options are limited.